ChenGuang Biotech Group Co., Ltd. (300138.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.91B
Enterprise Value8.61B
P/E Ratio16.16
PEG Ratio0.27
Price/Sales Ratio0.89
Price/Book Ratio1.58
Enterprise/Revenue1.6
Enterprise/EBITDA19.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.05
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.1

Income Statement

Revenue6.56B
Revenue/Share12.56
Gross Profit438.91M
EBITDA606.63M
Net Income368.87M
Diluted EPS0.76

Balance Sheet

Total Cash3.44B
Total Cash/Share7.12
Total Debt5.37B
Total Debt/Equity1.58
Current Ratio1.28
Book Value Per Share7.15

Price History

52-Week Change-14.62
52-Week High15.8
52-Week Low8.71
Moving Average 50 Days11.34
Moving Average 200 Days11.87

Statistics

Average Volume7.33M
Shares Outstanding483.1M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.69
Payout Ratio0.7
Last Split Factor7:5
Last Split DateJune 27, 2018
AD